Complications of corneal collagen cross-linking
Corneal collagen cross-linking (CXL) is an effective treatment for arresting progression in patients with keratoconus. CXL was approved by United States Food and Drug Administration for the treatment of progressive keratoconus in 2016. It is a relatively safe procedure with a low complication rate....
Main Authors: | Richa Agarwal, Parul Jain, Ritu Arora |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1466;epage=1474;aulast=Agarwal |
Similar Items
-
Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis
by: Francesco D’Oria, et al.
Published: (2021-09-01) -
Role of collagen cross linking in keratoconus
by: P V Nanda Kumar Reddy, et al.
Published: (2017-01-01) -
Tomographic changes after corneal collagen cross-linking for progressive keratoconus - one-year follow-up study
by: Petrović Tiana, et al.
Published: (2022-01-01) -
Progressive high-fluence epithelium-on accelerated corneal crosslinking: a novel corneal photodynamic therapy for early progressive keratoconus
by: Cosimo Mazzotta, et al.
Published: (2023-08-01) -
Long-Term Visual, Refractive and Topographic Outcomes of “Epi-off” Corneal Collagen Cross-Linking in Pediatric Keratoconus: Standard versus Accelerated Protocol
by: Amer I, et al.
Published: (2020-11-01)